Another day, another Johnson & Johnson recall. This time, the pharmaceutical giant is recalling 70,000 syringes filled with the schizophrenia drug Invega because of cracks in the syringes. The issue was discovered during routine testing at a Belgium manufacturing plant. The problem was resolved and production has resumed. The company says there have been no adverse events, infections or leakages due to the cracked syringes. The recall only affects the 234-milligram-strength injections.
This is just the latest in a string of recalls of Johnson & Johnson products over the past several months ranging from over-the-counter drugs to medical devices because of manufacturing problems.
On the over-the-counter drug front, Johnson & Johnson has recalled Tylenol, Benadryl, Motrin and Rolaids, which has taken a huge bite out of the company’s profits, not to mention its reputation. Its medical devices have also faltered.
Last December, the company recalled 492,000 boxes of 1-Day Acuvue TrueEye contact lenses because residual traces of an acid caused stinging users’ eyes. The lenses were sold in Japan, Australia, Hong Kong, U.K., France, Germany and Canada. Lenses sold in the U.S. were not affected by the recall because they are made with a different material.
Last summer, Johnson & Johnson’s subsidiary DePuy Orthopaedics issued a recall on artificial hip systems because the devices were failing at a higher than expected rate, causing many patients to undergo a second surgery to have their devices replaced. About 100,000 people worldwide have the recalled hip implant and must now be monitored for problems.